Hunt for clues to stop pancreatic cancer before it starts

NCT ID NCT06574373

Recruiting now Knowledge-focused Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Source: ClinicalTrials.gov ↗

Summary

This study aims to find better biological markers to predict which pancreatic cysts (called IPMNs) are likely to turn into cancer. Researchers will analyze tissue and blood samples from 3600 patients to understand the differences between low-risk and high-risk cysts. The goal is to help doctors make more accurate decisions about which patients need surgery and which can be safely monitored.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IPMN, PANCREATIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fondazione Policlinico Gemelli
RECRUITING

Roma, 00168, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••
IRCCS Fondazione Policlinico Universitario A. Gemelli
NOT_YET_RECRUITING

Rome, 00168, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

IPMN, PANCREATIC